Nos publications
Mise à jour novembre 2023
Pagination
- Page précédente
- Page 37
- Page suivante
Title | Authors | Year | Journal | Link to Article | Intended Audience Trier par ordre décroissant | Purpose |
---|---|---|---|---|---|---|
What should men living with haemophilia need to know? The perspectives of Canadian men with haemophilia | Arnold E, Lane S, Webert KE, Chan A, Walker I, Tufts J, Rubin S, Poon MC, Heddle NM | 2014 | Haemophilia | View What should men living with haemophilia need to know? The perspectives of Canadian men with haemophilia | Health care providers | Other |
Rivaroxaban and Apixaban induce clotting factor Xa fibrinolytic activity | Carter RLR, Talbot K, Hur WS, Meixner SC, Van Der Gugten JG, Holmes DT, Côté HCF, Kastrup CJ, Smith TW, Lee AYY, Pryzdial ELG | 2018 | J Thromb Haemost | View Rivaroxaban and Apixaban induce clotting factor Xa fibrinolytic activity | Health care providers | Basic research |
Safeguarding the Patient's Own Blood Supply | Zeller MP, Kaufman RM | 2019 | JAMA | View Safeguarding the Patient's Own Blood Supply | Health care providers | Clinical research |
Concentré de recherche: Transfusion de culots globulaires?: lien entre la non-concordance des sexes et la mortalité | Zeller M | 2019 | Blood.ca website | View Concentré de recherche: Transfusion de culots globulaires?: lien entre la non-concordance des sexes et la mortalité | Health care providers | Clinical research |
GRADE Guidelines 28: Use of GRADE for the assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks | Foroutan F, Guyatt G, Zuk V, Vandvik PO, Alba AC, Mustafa R, Vernooij R, Arevalo-Rodriguez I, Munn Z, Roshanov P, Riley R, Schandelmaier S, Kuijpers T, Siemieniuk R, Canelo-Aybar C, Schunemann H, Iorio A | 2020 | J Clin Epidemiol | View GRADE Guidelines 28: Use of GRADE for the assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks | Health care providers | Benchmarking and standard setting |
Blood Components | Gupta A, Bigham M | 2020 | Clinical Guide to Transfusion | View Blood Components | Health care providers | Benchmarking and standard setting |
Testing and management of fetal and neonatal alloimmune thrombocytopenia | Meunier D, Clarke G | 2020 | Blood.ca website | View Testing and management of fetal and neonatal alloimmune thrombocytopenia | Health care providers | Benchmarking and standard setting |
Déclaration des réactions transfusionnelles indésirables | Yan M | 2021 | Blood.ca website | View Déclaration des réactions transfusionnelles indésirables | Health care providers | Benchmarking and standard setting |
Implementation of measures to reduce vasovagal reactions: Donor participation and results | Goldman M, Uzicanin S, Marquis-Boyle L, O'Brien SF | 2021 | Transfusion | View Implementation of measures to reduce vasovagal reactions: Donor participation and results | Health care providers | Clinical research |
Blood Donation Testing and the Safety of the Blood Supply | Goldman M, Drews SJ | 2022 | Practical Transfusion Medicine | View Blood Donation Testing and the Safety of the Blood Supply | Health care providers | Benchmarking and standard setting |
FAQ: Canadian Blood Services platelet bacterial screening | Khandelwal A, Ramirez-Arcos S, Bigham M | 2022 | Blood.ca website | View FAQ: Canadian Blood Services platelet bacterial screening | Health care providers | Benchmarking and standard setting |
FAQ : Le sang total déleucocyté à la Société canadienne du sang | Mack J | 2022 | Blood.ca website | View FAQ : Le sang total déleucocyté à la Société canadienne du sang | Health care providers | New or improved product or process |
Circulaire d'information utilisation de composants sanguins humains: Sang total | Stewart T | 2022 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Sang total | Health care providers | Benchmarking and standard setting |
A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles | Akyurekli C, Le Y, Richardson RB, Fergusson D, Tay J, Allan DS | 2015 | Stem Cell Rev | View A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles | Health care providers | Clinical research |
Alloimmunization of patients by blood units harboring distinct DEL variants | St-Louis M, Lebrun A, Goldman M, Lavoie M | 2013 | Immunohematology | View Alloimmunization of patients by blood units harboring distinct DEL variants | Health care providers | Clinical research |
Anti-D; a type of IVIg | Khan R, Lazarus A | 2018 | Antibody Therapy: Substitution - Immunomodulation - Monoclonal Immunotherapy | View Anti-D; a type of IVIg | Health care providers | Other |
Blood-Borne Pathogens - A Canadian Blood Services Centre for Innovation Symposium | Walsh GM, Shih AW, Solh Z, Golder M, Schubert P, Fearon M, Sheffield WP | 2016 | Transfus Med Rev | View Blood-Borne Pathogens - A Canadian Blood Services Centre for Innovation Symposium | Health care providers | Other |
Counting platelets at transfusion threshold levels: impact on the decision to transfuse. A BEST Collaborative - UK NEQAS(H) International Exercise | Lozano M, Mahon A, van der Meer PF, Stanworth S, Cid J, Devine D, Fung MK, de la Salle B, Heddle NM, on behalf of Biomedical Excellence for Safer Transfusion Collaborative | 2014 | Vox Sang | View Counting platelets at transfusion threshold levels: impact on the decision to transfuse. A BEST Collaborative - UK NEQAS(H) International Exercise | Health care providers | Benchmarking and standard setting |
Expert approaches to common bleeding and thrombotic problems-part I | Hayward CP, Webert KE | 2012 | Semin Thromb Hemost | View Expert approaches to common bleeding and thrombotic problems-part I | Health care providers | Other |
Modeling of body weight metrics for effective and cost-efficient conventional factor VIII dosing in hemophilia A prophylaxis | McEneny-King A, Chelle P, Henrard S, Hermans C, Iorio A, Edginton AN | 2017 | Pharmaceutics | View Modeling of body weight metrics for effective and cost-efficient conventional factor VIII dosing in hemophilia A prophylaxis | Health care providers | Clinical research |
Peanut and fish allergy due to platelet transfusion in a child | Ching JC, Lau W, Hannach B, Upton JE | 2015 | CMAJ | View Peanut and fish allergy due to platelet transfusion in a child | Health care providers | Clinical research |
Platelet product quality remains high after seven days of storage | Serrano K, Schubert P, Devine D | 2017 | Blood.ca website | View Platelet product quality remains high after seven days of storage | Health care providers | New or improved product or process |
Pre-transfusion testing | Lane D | 2017 | Clinical Guide to Transfusion | View Pre-transfusion testing | Health care providers | Benchmarking and standard setting |
Questioning some recommendations in the umbilical cord blood guideline | Elmoazzen H, Petraszko T | 2018 | J Obstet Gynaecol Can | View Questioning some recommendations in the umbilical cord blood guideline | Health care providers | New or improved product or process |
Risks and trends of red blood cell transfusion in obstetric patients: a retrospective study of 45,213 deliveries using administrative data | Shehata N, Chassé M, Colas JA, Murphy M, Forster AJ, Malinowski AK, Ducharme R, Fergusson DA, Tinmouth A, Wilson K | 2017 | Transfusion | View Risks and trends of red blood cell transfusion in obstetric patients: a retrospective study of 45,213 deliveries using administrative data | Health care providers | Clinical research |
Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review | Poudel DR, Ghimire S, Dhital R, Forman DA, Warkentin TE | 2017 | Platelets | View Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review | Health care providers | Clinical research |
The Stem Cell Club: a model for unrelated stem cell donor recruitment | Fingrut W, Parmar S, Cuperfain A, Rikhraj K, Charman E, Ptak E, Kahlon M, Graham A, Luong S, Wang YG, Yu J, Arora N, Suppiah R, Li EW, Lee A, Welsh C, Benzaquen M, Thatcher A, Baharmand I, Ladd A, Petraszko T, Allan D, Messner H | 2017 | Transfusion | View The Stem Cell Club: a model for unrelated stem cell donor recruitment | Health care providers | New or improved product or process |
Transfusion reactions: prevention, diagnosis, and treatment | Delaney M, Wendel S, Bercovitz RS, Cid J, Cohn C, Dunbar NM, Apelseth TO, Popovsky M, Stanworth SJ, Tinmouth A, Van De Watering L, Waters JH, Yazer M, Ziman A | 2016 | Lancet | View Transfusion reactions: prevention, diagnosis, and treatment | Health care providers | Clinical research |
Utilization of frozen plasma in Ontario: a province wide audit reveals a high rate of inappropriate transfusions | Tinmouth A, Thompson T, Arnold DM, Callum JL, Gagliardi K, Lauzon D, Owens W, Pinkerton P | 2013 | Transfusion | View Utilization of frozen plasma in Ontario: a province wide audit reveals a high rate of inappropriate transfusions | Health care providers | Benchmarking and standard setting |
Cyclic thrombocytopenia with statistically significant neutrophil oscillations | Langlois GP, Arnold DM, Potts J, Leber B, Dale DC, Mackey MC | 2018 | Clin Case Rep | View Cyclic thrombocytopenia with statistically significant neutrophil oscillations | Health care providers | Clinical research |
Low platelet count as risk factor for infections in patients with primary immune thrombocytopenia: a retrospective evaluation | Qu M, Liu Q, Zhao H-G, Peng J, Ni H, Hou M, Jansen AJG | 2018 | Ann Hematol | View Low platelet count as risk factor for infections in patients with primary immune thrombocytopenia: a retrospective evaluation | Health care providers | Clinical research |
Diego System: Anti-Wra | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Diego System: Anti-Wra | Health care providers | Benchmarking and standard setting |
Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant | Douketis JD, Spyropoulos AC, Duncan J, Carrier M, Le Gal G, Tafur AJ, Vanassche T, Verhamme P, Shivakumar S, Gross PL, Lee AYY, Yeo E, Solymoss S, Kassis J, Le Templier G, Kowalski S, Blostein M, Shah V, MacKay E, Wu C, Clark NP, Bates SM, Spencer FA, Arnaoutoglou E, Coppens M, Arnold DM, Caprini JA, Li N, Moffat KA, Syed S, Schulman S | 2019 | JAMA Intern Med | View Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant | Health care providers | Benchmarking and standard setting |
Perinatal issues in transfusion practice | Lieberman L, Clarke G, Svensson A | 2020 | AABB Technical Manual, 20th Edition | Health care providers | Benchmarking and standard setting | |
Circulaire d'information utilisation de composants sanguins humains: Cellules progénitrices hématopoïétiques de sang de cordon ombilical | Stewart T | 2021 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Cellules progénitrices hématopoïétiques de sang de cordon ombilical | Health care providers | Benchmarking and standard setting |
Epidemiology, diagnosis and management of neonatal thrombosis: a single-center cohort study | Paes B, Chan AKC, Shaik M, Patel D, Bhatt MD | 2022 | Blood Coagul Fibrinolysis | View Epidemiology, diagnosis and management of neonatal thrombosis: a single-center cohort study | Health care providers | Clinical research |
Improving Medical Education in Hematology and Transfusion Medicine in Canada: Standards and Limitations | Laureano M, Mithoowani S, Tseng E, Zeller M | 2021 | Adv Med Educ Pract | View Improving Medical Education in Hematology and Transfusion Medicine in Canada: Standards and Limitations | Health care providers | Benchmarking and standard setting |
Chapter 16: Preoperative autologous donation | Foster T, Yan M | 2021 | Clinical Guide to Transfusion | View Chapter 16: Preoperative autologous donation | Health care providers | Benchmarking and standard setting |
Chapitre 10. Les réactions transfusionnelles | Laureano M, Khandelwal A, Yan M | 2022 | Guide de la pratique transfusionnelle | View Chapitre 10. Les réactions transfusionnelles | Health care providers | Benchmarking and standard setting |
A Mother and Newborn with Brown Blood | Estey MP, Clarke G, Sia W, Toor E, Higgins TN | 2015 | Clin Chem | View A Mother and Newborn with Brown Blood | Health care providers | Clinical research |
Acquired peanut hypersensitivity following platelet transfusion | Ponnampalam A, Growe G, Loftus P, Chipperfield K, Bigham M | 2014 | Transfus Med | View Acquired peanut hypersensitivity following platelet transfusion | Health care providers | Clinical research |
Bleeding complications in immune thrombocytopenia | Arnold DM | 2015 | Hematology Am Soc Hematol Educ Program | View Bleeding complications in immune thrombocytopenia | Health care providers | Clinical research |
CMV seronegative, irradiated and washed blood components | Prokopchuk-Gauk O, Solh Z | 2017 | Clinical Guide to Transfusion | View CMV seronegative, irradiated and washed blood components | Health care providers | Benchmarking and standard setting |
How we treat thrombotic thrombocytopenic purpura: Results of a Canadian TTP practice survey | Patriquin CJ, Clark WF, Pavenski K, Arnold DM, Rock G, Foley SR, for the Canadian Apheresis Group | 2016 | J Clin Apher | View How we treat thrombotic thrombocytopenic purpura: Results of a Canadian TTP practice survey | Health care providers | Clinical research |
Impact of Pandemic Influenza A (H1N1) on Laboratory Services | Patel SN, Gubbay JB, Bastien N, Booth T, Charest H, Chernesky M, Couillard M, Drews S, Garceau R, Gubbay J, Guercio S, Fearon M, Fonseca K, Hatchette T, Horsman G, Larke B, Li Y, Majury A, Ouellette O, Petric M, Ratnam S, Sevenhuysen C, Van Caeseele P | 2012 | National Collaborating Centre for Infectious Diseases: Evidence Reviews on Pandemic H1N1 | View Impact of Pandemic Influenza A (H1N1) on Laboratory Services | Health care providers | Other |
Les composants sanguins | Clarke G | 2017 | Guide de la pratique transfusionnelle | View Les composants sanguins | Health care providers | Benchmarking and standard setting |
Mortality outcomes in patients transfused with fresher versus older red blood cells: a meta-analysis | Chai-Adisaksopha C, Alexander PE, Guyatt G, Crowther MA, Heddle NM, Devereaux PJ, Ellis M, Roxby D, Sessler DI, Eikelboom JW | 2017 | Vox Sang | View Mortality outcomes in patients transfused with fresher versus older red blood cells: a meta-analysis | Health care providers | Clinical research |
Optimal transfusion practices after allogeneic hematopoietic cell transplantation: a systematic scoping review of evidence from randomized controlled trials | Christou G, Iyengar A, Shorr R, Tinmouth A, Saidenberg E, Maze D, Tay J, Bredeson C, Allan DS | 2016 | Transfusion | View Optimal transfusion practices after allogeneic hematopoietic cell transplantation: a systematic scoping review of evidence from randomized controlled trials | Health care providers | Clinical research |
Residual Risk of HIV, HCV and HBV in Canada | O'Brien SF, Yi Q-L, Fan W, Scalia V, Goldman M, Fearon MA | 2017 | Transfus Apher Sci | View Residual Risk of HIV, HCV and HBV in Canada | Health care providers | Clinical research |
The cost of transfusing a unit of red blood cells: a costing model for Canadian hospital use | Lagerquist O, Poseluzny D, Werstiuk G, Slomp J, Maier M, Nahirniak S, Clarke G | 2017 | ISBT Sci Ser | View The cost of transfusing a unit of red blood cells: a costing model for Canadian hospital use | Health care providers | Ethical, legal and social implications research |